Isoflurane reduction of carbachol-evoked cytoplasmic calcium transients is dependent on caffeine-sensitive calcium stores

Anesthesiology

Volumn 99, Issue 4, 2003, Pages 882-888

  Corrales, Alexandra ^b   Xu, Fang ^a   Garavito Aguilar, Zayra ^a   Blanck, Thomas J J ^a   Recio Pinto, Esperanza ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CALCIUM CHANNEL; CARBACHOL; FURA 2; INHALATION ANESTHETIC AGENT; ISOFLURANE; MUSCARINIC RECEPTOR; POTASSIUM CHLORIDE; RYANODINE;

ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN CELL; MINIMUM LUNG ALVEOLUS CONCENTRATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

CAFFEINE; CALCIUM; CALCIUM CHANNELS; CARBACHOL; CYTOPLASM; DRUG INTERACTIONS; HUMANS; ISOFLURANE; TUMOR CELLS, CULTURED;

EID: 0141543824     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200310000-00021     Document Type: Article

References (27)

1. Brann MR, Ellis J, Jorgensen H, Hill-Eubanks D, Jones SV: Muscarinic acetylcholine receptor subtypes: Localization and structure/function. Prog Brain Res. 1993; 98:121-7
2. Fibiger HC, Damsma G, Day JC: Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. Adv Exp Med Biol 1991; 295:399-414
3. Durieux ME: Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications. ANESTHESIOLOGY 1996; 84:173-89
4. Li DP, Chen SR, Pan YZ, Levey AI, Pan HL: Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol 2002; 543:807-18
5. Baba H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, Yoshimura M: Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol 1998; 508:83-93
6. Naguib M, Yaksh TL: Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 1997; 85:847-53
7. Bartolini A, Ghelardini C, Fantetti L, Malcangio M, Malmberg-Aiello P, Giotti A: Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol 1992: 105:77-82
8. Ghelardini C, Galeotti N, Bartolini A: Loss of muscarinic antinociception by antisense inhibition of M(1) receptors. Br J Pharmacol 2000; 129:1633-40
9. Shiraishi M, Minami K, Uezono Y, Yanagihara N, Shigematsu A: Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M1 receptors. J Pharmacol Exp Ther 2001; 299:255-60
10. Durieux ME: Inhibition by ketamine of muscarinic acetycholine receptor function. Anesth Analg 1995; 81:57-62
11. Minami K, Yanagihara N, Toyohira Y, Tsutsui M, Shigematsu A, Wada A, Izumi F: Isoflurane inhibits nicotinic acetylcholine receptor-mediated 22Na+ influx and muscarinic receptor-evoked cyclic GMP production in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol 1994; 349: 223-9
12. Durieux ME: Halothane inhibits signaling through m1 muscarinic receptors expressed in Xenopus oocytes. ANESTHESIOLOGY 1995; 82:174-82
13. Minami K, Minami M, Harris RA: Inhibition of 5-hydroxytryptamine type 2A receptor-induced currents by n-alcohols and anesthetics. J Pharmacol Exp Ther 1997; 281:1136-43
14. Do SH, Kamatchi GL, Durieux ME: The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: The role of protein kinase C. Anesth Analg 2001; 93:375-81
15. Ishizawa Y: Selective blockade of muscarinic receptor subtypes in the brain stem reticular formation in rats: Effects on anesthetic requirements. Brain Res 2000; 873:124-6
16. 2+ transients. ANESTHESIOLOGY 2000; 92:1746-56
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260:3440-50
18. Tanna B, Welch W, Ruest L, Sutko JL, Williams AJ: Interactions of a reversible ryanoid (21-ammo-9alpha-hydroxy-ryanodine) with single sheep cardiac ryanodine receptor channels. J Gen Physiol 1998; 112:55-69
19. Fill M, Copello JA: Ryanodine receptor calcium release channels. Physiol Rev 2002; 82:893-922
20. Fessenden JD, Wang Y, Moore RA, Chen SR, Allen PD, Pessah IN: Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line. Biophys J 2000; 79:2509-25
21. Zimanyi I, Buck E, Abramson JJ, Mack MM, Pessah IN: Ryanodine induces persistent inactivation of the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum. Mol Pharmacol 1992; 42:1049-57
22. Pancrazio JJ, Lynch C III: Differential anesthetic-induced opening of calcium-dependent large conductance channels in isolated ventricular myocytes. Pflugers Arch 1994; 429:134-6
23. Peterson BZ, DeMaria CD, Adelman JP, Yue DT: Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels. Neuron 1999; 22:549-58
24. Zuhlke RD, Pitt GS, Deisseroth K, Tsien RW, Reuter H: Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature 1999; 399:159-62
25. Karon BS, Autry JM, Shi Y, Garnett CE, Inesi G, Jones LR, Kutchai H, Thomas DD: Different anesthetic sensitivities of skeletal and cardiac isoforms of the Ca-ATPase. Biochemistry 1999; 38:9301-7
26. Martin AK, Nahorski SR, Willars GB: Complex relationship between Ins(1, 4, 5)P3 accumulation and Ca2+-signalling in a human neuroblastoma reveled by cellular dffferentiation. Br J Pharmacol 1999; 126:1559-66
27. Yamakage M, Kohro S, Matsuzaki T, Tsuchida H, Namiki A: Role of intracellular Ca2+ stores in the inhibitory effect of halothane on airway smooth muscle contraction. ANESTHESIOLOGY 1998; 89:165-73